Remove about responsibility
article thumbnail

Hidden compliance risks for life sciences companies

pharmaphorum

The life sciences history industry has some unique challenges when it comes to compliance. But if you think third party compliance risks are bad, don’t take your eye off fourth and fifth parties, says Allan Matheson. Some have an unfounded belief that enforcement agencies don’t care much about smaller companies.

article thumbnail

CDER’s Office of Compliance Kicks Off Annual Report Season with Rundown of 2023’s Major Public Health Enforcement Initiatives

FDA Law Blog

Claud — The Office of Compliance (OC) at FDA’s Center for Drug Evaluation and Research (CDER) had a role in many of the major public health enforcement matters you may have read about last year. One of 12 offices at CDER , a look at its annual report tells us a great deal about CDER’s enforcement priorities. By John W.M.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mastering 21 CFR Part 11 Compliance: A Comprehensive Guide for Clinical Trials in the Digital Age

Cloudbyz

21 CFR Part 11 is a crucial component of regulatory compliance in clinical trials and, more broadly, any industry subject to the regulations of the U.S. This blog post will serve as a comprehensive guide to understanding and implementing 21 CFR Part 11 compliance in your clinical trials. Food and Drug Administration (FDA).

article thumbnail

A Comprehensive Guide to Pharmacovigilance Regulatory Reporting: Ensuring Patient Safety and Compliance

Cloudbyz

This comprehensive guide delves into the essentials of pharmacovigilance regulatory reporting, highlighting its significance in maintaining drug and device safety, and ensuring compliance with regulatory requirements. Different types of reports have specific timelines for submission, and delays may result in regulatory actions or penalties.

article thumbnail

Optimizing Data Collection in Post-Surgical Pain Studies & The Role of Clinical Assessments

Worldwide Clinical Trials

However, the collection of accurate and reliable data in these pain studies presents a unique set of challenges, from the subjective nature of pain to the variability in patient compliance and assessment methodologies. Compliance Issues: Ensuring consistent patient participation in reporting pain levels post-surgery can be challenging.

article thumbnail

Clinical Trial Data Management Audit Checklist and Best Practices: Ensuring Data Integrity and Compliance

Cloudbyz

Clinical trial data management audits serve as a critical tool to evaluate and validate the accuracy, completeness, and integrity of the data, as well as compliance with regulatory requirements. Regulatory Compliance: Verification of compliance with applicable regulatory guidelines (e.g., auditors, regulatory authorities) 2.13.Regulatory

article thumbnail

As FDA inspections return, upholding compliance and maintaining GMP readiness is more crucial than ever

pharmaphorum

With attention and resources focused elsewhere during the pandemic, it’s likely that many facilities may have slipped into a state of non-compliance, which may result in unsuccessful inspections. Doing so means that businesses can check their compliance before an FDA inspection. About the Author. She has a Ph.D.